Abstracts must conform exactly to the following policies and procedures. Failure to submit your abstract as outlined below will mean that your abstract will not be considered for selection.
All abstracts are peer-reviewed and ranked on the basis of scientific merit. The GESA AGW 2019 Scientific Program Committee (SPC) will use these rankings to develop the final program.
You will be asked to supply 1 version of your paper: anonymous format.
To allow your abstract to be considered objectively and on an equal footing by the review panel, it is important that your loaded abstract does not contain the name(s) of the author(s) or of any other people. It also should not contain the name of any institution involved in any way in the research which is the subject of the abstract.
You will be asked to provide author and institution details when completing the “Contact Information” section on the abstract portal. These details will then be automatically added to your blind abstract to generate the authored version which will be published in the Journal of Gastroenterology and Hepatology’s abstract supplement (should you nominate it) and appear on the GESA AGW 2019 App.
4 Type of Presentation
Abstracts are allocated as oral Free Papers or as Poster Sessions, based on the breadth or focus of interest and other considerations.
5 Poster Presentation
Following assessment, the poster program will be developed in selected categories. The top ranked posters will form the Poster of Merit.
6 Publication Charge
A charge of AUD$95.00 (plus 10% GST – total $104.50) per submitted abstract will apply to cover various costs including the cost of publication in the Journal of Gastroenterology and Hepatology’s abstract supplement. Payments must be made by credit card, in Australian dollars, at the time of submission on the GESA AGW 2019 website.
All abstracts accepted will be published in the Journal of Gastroenterology and Hepatology’s abstract supplement, unless the submitting author requests otherwise.
8 Originality & Ethics
- At the time of submitting your abstract, the data must not have been presented at any other Australian meeting, nor published as a proffered paper in Australia.
- If your abstract has been presented at an international meeting but has not been published as a peer reviewed paper, it will be accepted to be presented in Australia.
- If the research presented was supported by a commercial organisation, a completed “Conflict of Interest” form must be submitted to the GESA office via the GESA AGW 2019 website.
- If the research involved human subjects, it must have been approved by your Institutional Review Board or Human Research Ethics Committee and conform to international standards of ethical practice. Animal research must have been approved by an appropriate Review Board and conform to the highest standards of human care.
9 Disclosure of Conflict of Interest
All abstract presenters are expected to disclose to the audience any significant financial interest or other relationship with the manufacturer of any commercial product(s) and/or provider(s) of commercial services discussed in the presentation; and any commercial supporters of the presentation.
The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship with a commercial company from making a presentation, but to provide the audience with information with which they can form their own opinions as to whether a presentation is biased or not. It remains for the audience to determine whether the speaker’s interests or relationships have influenced the presentation.
Significant financial interest or other relationship may include such things as:
- Support of individual or department research;
- Any support or financial incentives, current or past, which relate to the subject matter of the presentation;
- Any stock ownership or options, employment loan or financial relationship with a company whose product or service is directly connected to the topic of the presentation; and/or
- Being a consultant for a company whose product or service would be directly affected by the subject matter of the presentation.
No commercial literature or audiovisual material may be used. Trade or commercial names should be avoided unless necessary for clarity, and, where so used, should be accompanied by the name of the manufacturer.
All presentations must be free of any commercial bias.
An author of each abstract selected for participation in the program must attend the meeting and pay the relevant registration fee.
11 Instructions for Preparation
These categories are used to classify abstracts for review and publication. You will be asked to select one of these categories when uploading your abstract onto the GESA AGW 2019 website.
|Hepatology Basic Science||Animal Models, Lab based, in vitro work|
|Hepatology Clinical||Related to clinical observation in people with Liver diseases|
|Routine GI Endoscopy||Diagnostic gastroscopy and colonoscopy, capsule, diagnostic enteroscopy and upper GI bleeding|
|Advanced Endoscopic Techniques||GI stenting and dilatation, pancreatic, biliary and 3rd space procedures|
|Gastrointestinal Cancer||Single category to include Basic Science and Clinical|
|IBD Basic Science||Animal Models, Lab based, in vitro work|
|IBD Clinical||Related to clinical observation in people with IBD|
|Luminal Basic Science||Animal Models, Lab based, in vitro work.|
|Luminal Clinical||Related to clinical observation in patients/people.|
|Paediatrics||Clinical or basic research undertaken on paediatric patients or specifically relevant to paediatric diseases or patients|
The abstract title should be in sentence case (i.e. capitalise the first letter of the first word and any proper nouns only; do not use title case or all capitals).
Authors’ names should be supplied in the surname-last, forename initials format and should be in initial capital/lower case, not all capitals. Institution affiliations should be indicated with superscript numbers following each author name.
Please clearly indicate who the presenting author is, should your abstract be selected for participation in the program.
All affiliations should contain institution, city, state and country.
Sub-headings (e.g. Introduction, Methods, Results, Conclusions) should be included if appropriate for the work being presented.
References are optional and, where used, should be limited to a small number of the most essential references. References should follow the Vancouver style used in the Journal of Gastroenterology and Hepatology, with numbered citations given in the abstract text and a numbered reference list provided at the end of the abstract. References should be formatted as follows:
1 Vega KJ, Pina I, Krevsky B, Smith K. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann. Intern. Med. 1996; 124: 980–3.
For references with seven or more authors, list the first three followed by ‘et al.’
Tables & Graphs
Tables and figures can be included and must be cited in the abstract text. Do not submit graphs or tables as separate files. Try to ensure that any figures inserted in the abstract are of sufficient resolution (preferably 300 dpi) to be clearly legible when published. Please include headings or captions for all tables and figures.
The abstract itself must be formatted as text, not in table format.
Abbreviations should conform to the Style Manual for Biological Journals. Avoid abbreviations where possible, especially in the abstract title. Place abbreviations in parentheses after the full definition the first time it appears. Use no more than three (3) non-standard abbreviations.
Drug products mentioned in the abstract should be identified by their non-proprietary (i.e. generic) name only. Do not capitalise non-proprietary names.
Anonymous Version – File should be named so as to reflect the abstract title.
Authored Version – To enable your abstract to be identified, your surname must appear in the name of the abstract file, for example, "smithagw2019abstract"
Dos & Don’ts
• Ensure abstract does not exceed one (1) A4 sheet of paper.
• Keep italics and Greek symbols to the minimum required.
• Ensure that all track changes have been removed from the abstract.
• Proof read your abstract for completeness and accuracy.
• Use any font smaller than Times Roman 11 point (10 point on figures and footnotes) when printed;
• Indent at the beginning of paragraphs (just use a paragraph break);
You must submit your abstract online. Abstracts that do not comply with the above criteria will not be accepted.
Abstracts and payment must be received no later than 17:00 Australian Eastern Standard Time on Tuesday, 28 May 2019. No abstracts will be accepted after this date.
Oral Free Paper offers will be available via the GESA AGW 2019 Abstract Portal on the 22 July 2019. All authors will receive an email advising when to check the portal for their offer.
Poster offers will be available via the GESA AGW 2019 Abstract Portal on the 29 July 2019. All authors will receive an email advising when to check the portal for their offer.
Before submitting your abstract, check that you have:
- Removed all track changes
- Adhered to all requirements listed above (including ethics)
- Carefully proof read your abstract